Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severin Rodler

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Cureus|May 28, 2019
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell CarcinomaMarcus Schlemmer, Annabel Spek, Severin Rodler, et al.
Infection|September 6, 2020
Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinicsThilo Westhofen, Giuseppe Magistro, Simon Lennartz, et al.
The Journal of Pathology. Clinical Research|June 23, 2026
Ectonucleotidases CD39 and CD73 expression levels are independent and inverse predictors of survival in muscle-invasive bladder cancerStephan Ledderose, Julia Schwenke, Lennert Eismann, et al.
Clinical Genitourinary Cancer|June 13, 2020
Patients' Perspective on Digital Technologies in Advanced Genitourinary CancersSeverin Rodler, Alexander Buchner, Christian G Stief, et al.
Cureus|March 2, 2022
Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological OutcomesMichael Staehler, Tina Schuler, Annabel Spek, et al.
Urologie (Heidelberg, Germany)|February 4, 2026
[Innovative imaging techniques for urothelial carcinoma]Jakob Kohler, Severin Rodler, Julian Andersson, et al.
Journal Fur Urologie Und Urogynakologie : Zeitschrift Fur Urologie Und Urogynakologie in Klinik Und Praxis|December 28, 2020
[Digital innovation in medicine: the COVID-19 pandemic as an accelerator of "digital health"]Jan-Niclas Mumm, Severin Rodler, Maja-Lena Mumm, et al.
Der Urologe. Ausg. A|January 5, 2021
[Systemic treatment of bladder cancer]Alexander Tamalunas, Gerald B Schulz, Severin Rodler, et al.
Cancers|May 16, 2023
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder CancerStephan Ledderose, Severin Rodler, Lennert Eismann, et al.
Clinical Genitourinary Cancer|November 20, 2023
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not AnecdotalMichael Staehler, Severin Rodler, Isabel Brinkmann, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Cureus|May 28, 2019
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell CarcinomaMarcus Schlemmer, Annabel Spek, Severin Rodler, et al.
Infection|September 6, 2020
Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinicsThilo Westhofen, Giuseppe Magistro, Simon Lennartz, et al.
The Journal of Pathology. Clinical Research|June 23, 2026
Ectonucleotidases CD39 and CD73 expression levels are independent and inverse predictors of survival in muscle-invasive bladder cancerStephan Ledderose, Julia Schwenke, Lennert Eismann, et al.
Clinical Genitourinary Cancer|June 13, 2020
Patients' Perspective on Digital Technologies in Advanced Genitourinary CancersSeverin Rodler, Alexander Buchner, Christian G Stief, et al.
Cureus|March 2, 2022
Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological OutcomesMichael Staehler, Tina Schuler, Annabel Spek, et al.
Urologie (Heidelberg, Germany)|February 4, 2026
[Innovative imaging techniques for urothelial carcinoma]Jakob Kohler, Severin Rodler, Julian Andersson, et al.
Journal Fur Urologie Und Urogynakologie : Zeitschrift Fur Urologie Und Urogynakologie in Klinik Und Praxis|December 28, 2020
[Digital innovation in medicine: the COVID-19 pandemic as an accelerator of "digital health"]Jan-Niclas Mumm, Severin Rodler, Maja-Lena Mumm, et al.
Der Urologe. Ausg. A|January 5, 2021
[Systemic treatment of bladder cancer]Alexander Tamalunas, Gerald B Schulz, Severin Rodler, et al.
Cancers|May 16, 2023
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder CancerStephan Ledderose, Severin Rodler, Lennert Eismann, et al.
Clinical Genitourinary Cancer|November 20, 2023
Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not AnecdotalMichael Staehler, Severin Rodler, Isabel Brinkmann, et al.
Pageof 13